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Oligoadenylate synthetases play an important role in the immune response against dengue
virus.  Single nucleotide polymorphisms in the oligoadenylate synthetases genes are known
to  affect oligoadenylate synthetases activity and are associated with outcome of viral infec-
tions. Polymorphisms in the OAS1 SNPs (rs1131454), OAS2 SNPs (rs1293762, rs15895 and
rs1732778)  and OAS3 SNPs (rs2285932 and rs2072136) genes were studied using PCR followed
by  restriction fragment length polymorphism methods in 30 patients for dengue infec-
tion  and 40 control group who have no documented evidence of symptomatic dengue. An
increase  in the frequency of OAS2 gene rs1293762 SNP G/T heterozygotes (p = 0.012), decrease
in  the frequency of SNP G/G homozygotes (p = 0.005) and decrease in the frequency of OAS2
gene  rs1732778 SNP G/G homozygotes (p = 0.000017) and A/A homozygotes (p = 0.0000012)
were  observed among the dengue patients compared with control group. Our results sug-gest  that OAS2 haplotypes are associated with differential susceptibility to clinical outcomes
of  dengue virus infection.
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDDengue has emerged as a global health problem, as evidenced
by  a series of epidemics throughout the tropical, subtropical
and  temperate regions of the world.1 Dengue virus (DENV),
member of the ﬂavivirus genus of the Flaviviridae family,
is  an enveloped and mosquito borne virus that contains a
single-stranded, positive sense RNA genome. DENV infec-
tion  can lead to dengue fever (DF), dengue hemorrhagic fever
(DHF),  and dengue shock syndrome (DSS). The WHO  has
reported  that DENV infection causes an estimated 50–100
million  cases of DF and several hundred thousand cases of
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1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licençaDHF/DSS annually around the world.2 The pathophysiology of
dengue  virus (DENV) infection is multifactorial involving com-
plex  interactions among viral and host factors such as human
leukocyte  antigens and cytokines.3
The 2′-5′-oligoadenylate synthetase (2′-5′-OAS) endori-
bonuclease L (RNase L) pathway is an important component of
the  antiviral intracellular innate immune response in mam-
malian  cells.4 OAS gene expression is induced by type I
interferons and type II interferons. Viral double-stranded RNA
or single-stranded RNA can activate 2-5-OAS to polymerize
′ ′ ′ ′short 2 -5 -linked oligoadenylate. 2 -5 -Linked oligoadenylate
binds to latent RNase L, which causes its dimerization
and activation. The activated RNase L cleaves both cellular
RNA  and viral RNA molecules, resulting in degradation of
 de CC BY-NC-ND
 2 0 1 
p
p
a
s
g
g
w
R
p
a
u
d
K
r
y
S
r
p
v
g
p
g
s
w
t
d
(
O
p
s
c
t
ab r a z j i n f e c t d i s .
rotein synthesis and inhibition of virus replication.5 In the
resent  study, the possible association of six SNPs distributed
cross  the three human OAS genes with predisposition to
evere  dengue virus infection-induced disease was  investi-
ated.
Blood  samples were  obtained from dengue patients, who
ave  informed consent for participation in the research, which
as  approved by the Ethical Committee of the Institute of
egional  Medical Research Centre, Port Blair. A total of 30 sam-
les  were  obtained from patients with dengue virus infection
nd  compared with random control samples from 40 individ-
als  living in the Andaman Islands with no information about
engue  virus infection.
DNA  was  extracted by using the QIAmp DNA Blood Maxi
it  (Qiagen) and stored at −20 ◦C before use. Polymerase chain
eaction  and restriction fragment length polymorphism anal-
sis  was  performed to genotype OAS1 SNP rs1131454, OAS2
NPs  rs1293762, rs15895, and rs1732778 and the OAS3 SNPs
s2285932  and rs2072136 in dengue samples and control sam-
les  as previously described.5 The restriction products were
isualized  on either 2% agarose gels. Individual SNP allele and
enotype  frequencies and haplotype frequencies were com-
ared  between patients with dengue infection and control
roups  using Chi-square and Fisher exact test using (EpiInfo 7
oftware – www.cdc.gov/epiinfo/). Differences between groups
ere considered signiﬁcant at p < 0.05. Permutation tests using
he  EM algorithm were  applied to analyze pair-wise linkage
isequilibrium between SNPs.
A total of six SNPs located in different regions of the OAS1
1SNPs),  OAS2 (3SNPs) and OAS3 (SNPs2) genes were selected.
AS  SNPs were  genotyped in 30 DNA samples from dengue
atients  and 40 DNA samples from control group. Statistically
igniﬁcant differences in the genotype between the dengue
ases  and healthy controls were  observed. Characteristics of
hese  SNPs in multiple OAS1, OAS2, and OAS3 gene transcripts
re  indicated in Table 1.
Table 1 – Statistical association of single nucleotide polymorph
Gene SNP, variable Genotype frequency Dengue cases n = 30 (%) 
OAS1 rs1131454 AA 23.3 
AG 70 
GG 6.6 
OAS2 rs1293762 GG 33.3 
GT 60 
TT 6.6 
rs15895 GG 76.6 
GA 23.3 
AA 0 
rs1732778 GG 0 
GA 0 
AA 100 
OAS3 rs2285932 CC 40 
CT 50 
TT 10 
rs2072136 GG 20 
GA 36.6 
AA 43.3 4;1 8(5):548–550  549
An increased frequency of OAS2 gene rs1293762 SNP  G/T
heterozygotes was  observed among dengue patients when
compared  with control group. The difference was  statistically
signiﬁcant (p = 0.012, OR = 3.954, 95% CI: 1.294–12.254). The fre-
quency  of OAS2 gene r1293762 SNP G/G homozygotes was
signiﬁcantly decreased among dengue patients compared
to  control group (p = 0.005, OR = 0.124, 95% CI: 0.068–0.659).
Likewise, the frequency of OAS2 gene rs1732778 SNP
G/G  homozygotes and A/A homozygotes was signiﬁcantly
decreased among dengue patients compared to control group
(p  = 0.000017, OR = 0.000, 95% CI: 0.000–0.159 and p = 0.0000012,
OR  = 42.000, 95% CI: 7.745–396.49, respectively). No signiﬁcant
association with dengue infection was  observed for OAS1
gene  rs1131454 SNP homozygotes AA (p = 0.315), GG (p = 0.687)
and  heterozygote AG (p = 0.151); OAS3 gene rs2285932 SNP
homozygotes CC (p = 0.692), TT (p = 0.198) and CT (p = 0.703) and
rs2072136  SNP homozygotes GG (p = 0.913), AA (p = 0.502) and
GA  (p = 0.805) SNPs.
The severity of DENV infection is determined by complex
factors including magnitude of DENV replication, expression
of  cytokines, activation and proliferation of immune cells, host
genetic  factors, etc.6,7 As patients with DHF/DSS tend to have
higher  viremia titers than patients with dengue fever, DENV
levels  appear to be associated with the severity of dengue
diseases.8,9 Oligoadenylate synthetase is well known as an
IFN  induced antiviral pathway, which plays a critical role in
innate  immunity, controlling the outcome of virus produc-
tion.  The OAS3 protein preferentially catalyzes the synthesis
of  dimeric 2′-5′-linked Oligoadenylate that binds to RNase
L  with lower afﬁnity and induces less activation than the
trimeric  and longer oligomers synthesized by the OAS1 and
OAS2  proteins.10 OAS3 has been reported to have antiviral
activity against the alphavirus chikungunya.11The anti-DEN activities of these three OAS isoforms corre-
lated  with their ability to trigger RNase L activation in DENV
infected  cells. However, OAS1 p42/p46 and OAS3 p100 are likely
isms for dengue cases compared to healthy individuals.
Control group n = 40 (%) p-Value OR 95% CI
37.5 0.315 0.507 0.148–16304
50 0.151 2.333 0.777–7.225
12.5 0.687 0.500 0.044–3.372
70 0.005 0.214 0.068–0.659
27.5 0.012 3.954 1.294–12.254
2.5 0.798 2.785 0.136–168.480
85 0.564 0.579 0.141–2.326
12.5 0.384 2.130 0.505–9.519
2.5 0.884 0.000 0.000–52.000
65 0.000017 0.000 0.000–0.159
25 0.090 0.214 0.021–1.157
10 0.0000012 42.000 7.745–396.499
32.5 0.692 1.384 0.459–4.145
42.5 0.703 1.352 0.470–3.893
25 0.198 0.333 0.054–1.500
30 0.913 1.202 0.393–3.633
32.5 0.805 1.274 0.434–3.720
37.5 0.502 0.583 0.155–2.011
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to contribute to host defense against DENV infection and play
a  role in determining the outcomes of DEN disease.12
2′-5′-OAS controls DENV replication and provides insights
into  the antiviral capacity of various members of the OAS fam-
ily  against DENV replication. The antiviral effects of human
OAS1  p42, OAS1 p46, and OAS3 p100 correlate with their abili-
ties  to trigger RNase L activation in DENV-2 infected cells.12
It would be interesting to determine whether these three
OAS  isoforms also contribute to host defense against other
ﬂaviviruses and whether they are candidate human genetic
factors  for determining human susceptibility and severity of
DENV-related  diseases.
Associations  between two SNPs located within the OAS2
gene  and the outcome of dengue virus infection were detected
in  the present study. However, in the present cohort there
was  no evidence of a signiﬁcant association between DENV
infection  and OAS1 SNP rs1131454, OAS3 SNPs rs2285932
and  rs2072136. Of these OAS genes SNPs were  deviated from
Hardy–Weinberg equilibrium (HWE), but were not signiﬁcantly
associated with dengue virus infection. Another study13 sug-
gested  that Hardy–Weinberg equilibrium was  not signiﬁcantly
associated with West Nile virus infection or disease progres-
sion  from 360 SNPs distributed across 86 genes.
An association was  noticed between the OAS1 gene rs2660
SNP  located in the 3-untranslated region of p46 and the out-
come  of infection with another member of the Flaviviridae
family namely hepatitis C virus.14 In the present study no
association was  found between any of the OAS1 gene SNP
and  OAS3 SNPs tested and human susceptibility to dengue
virus.  A recent study showed that OAS1-OAS3-OAS2 hap-
lotypes  were  associated with differential susceptibility to
clinical  outcomes of dengue infection.15 In the present study
data  obtained from the analysis of OAS gene SNPs suggest that
variation  in this component of the innate immune response
could  contribute to the outcome of dengue virus infection.
Nonetheless, data from additional cohorts are needed to fur-
ther  validate these results; identiﬁcation of genetic variants
that  control the innate immune response will provide an
increased  understanding the mechanisms of viral pathogen-
esis.
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